Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)
Authors:
- S. KatayamaSKS. Katayama
- for the Japan Diabetes Complications Study GroupFGfor the Japan Diabetes Complications Study Group
- S. TanakaSTS. Tanaka
- H. SoneHSH. Sone
Open Access
- 1 February 2011
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 54 (5) , 1025-1031
Abstract
Aims/hypothesis The aim of the study was to determine the transition rate and factors associated with the progression of normo- and low microalbuminuria to diabetic nephropathy (overt proteinuria). Methods For 8 years we prospectively observed 1,558 Japanese patients with type 2 diabetes mellitus whose basal urinary albumin:creatinine ratio (UACR) had been measured as 33.9 mg/mmol) was determined by measuring UACR twice a year. Results Progression to nephropathy occurred in 74 patients. The annual transition rate was 0.67%, and was substantially higher for the low-microalbuminuric group than for the normoalbuminuric group (1.85% and 0.23%, respectively; hazard ratio for the low-microalbuminuric group 8.45, p < 0.01). The hazard ratio for an HbA1c of 7–9% or ≥9% was 2.72 (p < 0.01) or 5.81 (p < 0.01) relative to HbA1c p = 0.06) and 3.54 (p < 0.01), respectively. Smoking also affected progression to proteinuria (hazard ratio 1.99, p < 0.01). In contrast, 30.3% of the low-microalbuminuric group returned to normoalbuminuria (i.e. were in remission). Conclusions/interpretation These results suggest that if patients with type 2 diabetes mellitus are receiving treatment from diabetologists for hyperglycaemia and hypertension when they are in the early stages of nephropathy (i.e. normo- or low microalbuminuria), their rate of transition to proteinuria is considerably lowered, and that differentiating patients with low microalbuminuria from those with high microalbuminuria might be clinically useful. Trial registration UMIN Clinical Trials Registry C000000222 Funding The study was funded by the Ministry of Health, Labour and Welfare, Japan.Keywords
This publication has 22 references indexed in Scilit:
- Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study)Diabetologia, 2010
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- An overview of dialysis treatment in Japan (as of Dec. 31, 2007)Nihon Toseki Igakkai Zasshi, 2009
- Prevention of Transition From Incipient to Overt Nephropathy With Telmisartan in Patients With Type 2 DiabetesDiabetes Care, 2007
- Risk Factors for Renal Dysfunction in Type 2 DiabetesDiabetes, 2006
- Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)Kidney International, 2003
- Effects of Lifestyle Modifications on Patients with Type 2 Diabetes: The Japan Diabetes Complications Study (JDCS) Study Design, Baseline Analysis and Three Year-Interim ReportHormone and Metabolic Research, 2002
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Incidence and Determinants of Elevated Urinary Albumin Excretion in Pima Indians With NIDDMDiabetes Care, 1995